{"@context":{"ns0":"http://www.ebi.ac.uk/efo/","rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","owl":"http://www.w3.org/2002/07/owl#","rdfs":"http://www.w3.org/2000/01/rdf-schema#","obo_purl":"http://purl.obolibrary.org/obo/","oboinowl_gen":"http://www.geneontology.org/formats/oboInOwl#","metadata_def":"http://data.bioontology.org/metadata/def/","metadata":"http://data.bioontology.org/metadata/"},"@id":"ns0:EFO_0005513","@type":"owl:Class","rdfs:subClassOf":{"@id":"ns0:EFO_0001444"},"rdfs:label":"progesterone receptor status","obo_purl:IAO_0000115":"quantification of progesterone receptors in breast cancer. PR status is used in the classification of breast cancers.","obo_purl:IAO_0000117":"Dani Welter","obo_purl:IAO_0000136":{"@id":"ns0:EFO_0000305"},"oboinowl_gen:hasDbXref":"NCIt:C16149","metadata:def/prefLabel":"progesterone receptor status","metadata:def/mappingLoom":"progesteronereceptorstatus","metadata:def/mappingSameURI":{"@id":"ns0:EFO_0005513"},"metadata:prefixIRI":"efo:EFO_0005513"}
{"@context":{"ns0":"http://www.ebi.ac.uk/efo/","rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","owl":"http://www.w3.org/2002/07/owl#","rdfs":"http://www.w3.org/2000/01/rdf-schema#","obo_purl":"http://purl.obolibrary.org/obo/","oboinowl_gen":"http://www.geneontology.org/formats/oboInOwl#","metadata_def":"http://data.bioontology.org/metadata/def/","metadata":"http://data.bioontology.org/metadata/"},"@id":"ns0:EFO_0005513","@type":"owl:Class","rdfs:subClassOf":{"@id":"ns0:EFO_0001444"},"rdfs:label":"progesterone receptor status","obo_purl:IAO_0000115":"quantification of progesterone receptors in breast cancer. PR status is used in the classification of breast cancers.","obo_purl:IAO_0000117":"Dani Welter","obo_purl:IAO_0000136":{"@id":"ns0:EFO_0000305"},"oboinowl_gen:hasDbXref":"NCIt:C16149","metadata:def/prefLabel":"progesterone receptor status","metadata:def/mappingLoom":"progesteronereceptorstatus","metadata:def/mappingSameURI":{"@id":"ns0:EFO_0005513"},"metadata:prefixIRI":"efo:EFO_0005513"}